NEW YORK, Oct. 9-CuraGen plans to make an announcement regarding cash flow and expenditures early next year, investor relations and corporate communications director Mark Vincent said at the UBS Warburg global life sciences conference here today.
Get the full story
This story is free
for registered users
Registering provides access to this and other free content.
Register now.Already have an account?
Login Now.